Bioline Rx Book Value Per Share:
0.9154 for March 31, 2013Bioline Rx Historical Book Value Per Share Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.9154 |
| Dec. 31, 2012 | 0.8181 |
| Sept. 30, 2012 | 1.047 |
| June 30, 2012 | 1.353 |
| March 31, 2012 | |
| Dec. 31, 2011 | 1.823 |
About Book Value per Share
Book value per share indicates the book value (or accounting value) of each share of stock. Book value is a company's net asset value, which is calculated by total assets minus intangible assets and liabilities. A relatively high book value per share in relation to stock price often occurs when a stock is undervalued.
In the rare circumstance that market price falls below the book value per share, generally a stock is undervalued and might be an attractive buy.
Learn More
BLRX Book Value Per Share Benchmarks
| Companies | |
|---|---|
| Oramed Pharmaceuticals | 0.7266 |
| Achillion Pharmaceuticals | 2.020 |
| Shire | 20.16 |
BLRX Book Value Per Share Range, Past 5 Years
| Minimum | 0.8181 | Dec 2012 |
| Maximum | 1.823 | Dec 2011 |
| Average | 1.191 |
BLRX News
BioLineRx (BLRX) Enrolls First Patients in BL-8020 Phase I/II as HCV Treatment
Street Insider Apr 29
Street Insider Apr 29